© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

More articles

More articles

More articles

  • A weekend of hostile rhetoric between Iran and the US has caused equity capital markets bankers to consider delaying new deals from the Middle East despite a healthy issuance pipeline, over fears that the two countries are gearing up for war.
  • Hong Kong-listed MicroPort Scientific Corp is looking at spinning off and listing its heart treatment subsidiary, according to a stock exchange filing.
  • I-Mab, a China-based biopharmaceutical company, has kicked off the roadshow for its up to $111.1m Nasdaq IPO, more than two months after filing draft documents with the US regulator.
  • Equity capital markets bankers' bullish mood was dented on Friday by falling markets as investors reacted to escalating tension in the Middle East after the US assassination of Iranian general Qasem Soleimani. Banks are hoping this change in sentiment does not damage deal making next week.
  • Property manager Central China New Life is planning to list in Hong Kong in the first quarter, said a source familiar with the transaction.
  • Smoore International Holdings, a manufacturer of vaping technology, is lining up a Hong Kong IPO of more than $500m in the first quarter of 2020, according to a source familiar with the matter.
shared comment list